Evidence map›Paper›PMID 23507255›Full record

ReviewJournal of molecular and cellular cardiology2013

Dysfunctional ryanodine receptors in the heart: new insights into complex cardiovascular diseases.

Steven O Marx, Andrew R Marks

Abstract readReview
In one paragraph

Review in Journal of molecular and cellular cardiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Structural Integrity of RyR2 Clusters Controls Cardiac Calcium Leak.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Structural insights into the regulation of RyR1 by S100A1.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Targeting ryanodine receptors to treat human diseases.The Journal of clinical investigation · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Steven O MarxDivision of Cardiology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.
Andrew R Marks
Columbia University · US

Funding

Molecular Basis of Sudden Cardiac DeathP01HL067849 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARKS, ANDREW ROBERT · 2001 to 2011
$15.0M
REGULATION OF RYANODINE RECEPTORS BY ALLOSTERIC MODULATIONP01HL081172 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KARLIN, ARTHUR · 2007 to 2011
$7.3M
MOLECULAR BASIS OF HEART FAILURER01HL061503 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARKS, ANDREW ROBERT · 1998 to 2016
$6.5M
CARDIAC AND SKELETAL MUSCLE CALCIUM RELEASE CHANNELSR01HL056180 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF CUNY · PI MARKS, ANDREW ROBERT · 1996 to 2009
$4.0M
Intracellular calcium leak and muscle functionR01AR060037 · NIAMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARKS, ANDREW ROBERT · 2010 to 2014
$1.7M
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular CalciR01HL102040 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARKS, ANDREW ROBERT · 2011 to 2014
$1.6M
Regulation of cardiac ion channel function via allosteric modulatorsR01HL083418 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARKS, ANDREW ROBERT · 2006 to 2007
$841k
NHLBI NIH HHS P01 HL067849NHLBI NIH HHS P01 HL081172NHLBI NIH HHS R01 HL056180NHLBI NIH HHS R01 HL061503NHLBI NIH HHS R01 HL083418NHLBI NIH HHS R01 HL102040NIAMS NIH HHS R01 AR060037
6 · The paper itself

Abstract

Calcium dependent signaling is highly regulated in cardiomyocytes and determines the force of cardiac muscle contraction. The cardiac ryanodine receptors (RyR2) play important roles in health and disease. Modulation of RyR2 by phosphorylation is required for sympathetic regulation of cardiac function. Abnormal regulation of RyR2 contributes to heart failure, and atrial and ventricular arrhythmias. RyR2 channels are oxidized, nitrosylated, and hyperphosphorylated by protein kinase A (PKA) in heart failure, resulting in "leaky" channels. These leaky RyR2 channels contribute to depletion of calcium from the sarcoplasmic reticulum, resulting in defective cardiac excitation-contraction coupling. In this review, we discuss both the importance of PKA and calcium/calmodulin-dependent kinase II (CaMKII) regulation of RyR2 in health, and how altered phosphorylation, nitrosylation and oxidation of RyR2 channels lead to cardiac disease. Correcting these defects using either genetic manipulation (knock-in) in mice, or specific and novel small molecules ameliorates the RyR2 dysfunction, reducing the progression to heart failure and the incidence of arrhythmias.

Indexed as

Calcium SignalingAnimalsArrhythmias, CardiacCalcium-Calmodulin-Dependent Protein Kinase Type 2Cyclic AMP-Dependent Protein KinasesExcitation Contraction CouplingHeart FailureHumansMiceMyocardial ContractionMyocardiumMyocytes, CardiacRyanodine Receptor Calcium Release ChannelCalcium-Calmodulin-Dependent Protein Kinase Type 2Cyclic AMP-Dependent Protein KinasesRyanodine Receptor Calcium Release Channel

Identifiers

PMID23507255
PMCPMC4042628
OpenAlexW2091389403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.